ADTX

Q: What is the price of ADiTx Therapeutics (ADTX) today?

The price of ADiTx Therapeutics (ADTX) today is $ 0.73, with return of -99.98% compared to the last year. The price of ADiTx Therapeutics (ADTX) started the year trading around $ 0.83 and today it is at $ 0.73. Follow the real-time price chart, the historical price of ADiTx Therapeutics (ADTX) and international markets.

Q: When does ADiTx Therapeutics (ADTX) pay dividends?

ADiTx Therapeutics (ADTX) did not distribute dividends in the last year.

Q: Is ADiTx Therapeutics (ADTX) worth it?

Currently, ADiTx Therapeutics (ADTX) is priced at $ 0.73, with a P/E of -0.04%, representing a deviation of -30,424,184% from its historical average P/E. In the last year, the stock showed a variation of -99.98 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -99.98%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy ADiTx Therapeutics (ADTX) stock?

Investing in stocks of ADiTx Therapeutics (ADTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of ADiTx Therapeutics (ADTX) yield today?

The yield of ADiTx Therapeutics (ADTX) was -49.31% in the last month, -99.98% in the last year and -100.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of ADiTx Therapeutics (ADTX) today, the total investment would be $ 73.00, based on the current price of $ 0.73.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.01In 5 years: $ 0.00In 10 years: $ 73.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ADiTx Therapeutics Inc.

Price

$ 0.73

return (12m)

-99.98%

p/e

-0.04

p/bv

-0.18

DIVIDEND YIELD

0.00%

price ADTX

ADTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ADTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-49.31%

3 months

-98.47%

1 year

-99.98%

2 years

-100.00%

5 years

-100.00%

10 years

0.00%

Fundamentals ADTX

review the fundamentals of ADiTx Therapeutics shares

P/E

-0.04

Sector: -3.66 Industry: -3.66

P/SALES RATIO (PSR)

Sector: -3.63 Industry: -3.63

P/BV

-0.18

Sector: 2.08 Industry: 2.08

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-358.05%

Sector: -63.97% Industry: -63.97%

ROE

476.86%

Sector: -66.68% Industry: -66.68%

ROIC

-40.10%

Sector: -1,128.96% Industry: -1,128.96%

NET MARGIN

0.00%

Sector: -41.05% Industry: -41.05%

GROSS MARGIN

0.00%

Sector: 39.22% Industry: 39.22%

OPERATING MARGIN

0.00%

Sector: -40.98% Industry: -40.98%

P/EBITDA

-0.04

Sector: -3.63 Industry: -3.63

P/EBIT

-0.04

Sector: -3.76 Industry: -3.76

P/ASSET

0.13

Sector: 1.47 Industry: 1.47

BVPS

-4.43

Sector: 1.77 Industry: 1.77

EPS

-21.13

Sector: -2.03 Industry: -2.03

EQUITY RATIO

-0.75

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-1.84%

Sector: - Industry: -

Fundamentals ADTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.59	6.21	31.69%	2.51%	$ 492.17 B	27.26%
PFE	14.74	1.56	10.56%	6.75%	$ 144.85 B	15.65%
ABBV	169.26	-155.52	-91.88%	2.87%	$ 404.20 B	4.00%
NVO	16.95	9.78	57.70%	2.87%	$ 261.35 B	32.78%
MRK	14.51	0.00	0.00%	2.97%	$ 276.10 B	29.63%
AZN	31.24	6.39	20.45%	1.65%	$ 293.60 B	16.17%
BMY	18.61	6.04	32.47%	4.49%	$ 112.40 B	12.57%
GILD	18.56	7.02	37.80%	2.61%	$ 150.53 B	27.88%
ZTS	21.25	10.44	49.11%	1.57%	$ 56.34 B	28.21%
REGN	18.10	2.68	14.79%	0.44%	$ 82.84 B	32.13%
HALO	14.24	16.83	118.17%	0.00%	$ 8.48 B	47.91%
AMGN	25.05	18.24	72.82%	2.92%	$ 175.44 B	19.47%
MCK	25.09	-175.07	-697.75%	0.38%	$ 101.19 B	1.04%
VRTX	32.31	6.86	21.22%	0.00%	$ 118.75 B	31.35%
CAH	30.01	-17.53	-58.40%	1.01%	$ 47.86 B	0.68%
ADMA	20.48	9.95	48.57%	0.00%	$ 4.29 B	42.87%
BIIB	17.15	1.51	8.83%	0.00%	$ 27.58 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ADTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY ADiTx Therapeutics

ADiTx Therapeutics Inc.

Average user rating I10

4.0 (1 people)

United States

9 years

Founded: 2017

2020

Time since IPO - 6 years

6

Employees

The Company ADiTx Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 1.58 Million, having an equity of $ -8.86 Millions.

With a total of 6 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -42.25 Millions.

As for its main indicators, the Company has a P/E ratio of -0.04, a P/BV ratio of -0.18 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ADTX.

Market cap

$ 1.58 Million

Net worth

$ -8.86 Millions

US$ -8,860,000.00

Assets

$ 11.80 Millions

US$ 11,800,000.00

Total Shares Outstanding

2.00 Millions

2,000,000

Average Daily Trading Volume

$ 1.89 Million

US$ 1,885,860.70

Sector

Health Care

Industry

Biotechnology

ADTX

ADTX revenue and profits

Financial Results ADTX

DRAG THE FRAME TO SEE MORE DATA

ADTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 834.16 43,58% (12M)

P/E

25.09

0.38%

ROE

-697.75%

P/BV

-175.07

CAH - Cardinal Health

$ 213.56 73,39% (12M)

P/E

30.01

1.01%

ROE

-58.40%

P/BV

-17.53

JNJ - Johnson & Johnson

$ 218.55 56,36% (12M)

P/E

19.59

2.51%

ROE

31.69%

P/BV

6.21

MRK - Merck & Co.

$ 111.01 15,08% (12M)

P/E

14.51

2.97%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.58 5,33% (12M)

P/E

14.74

6.75%

ROE

10.56%

P/BV

1.56

ABBV - AbbVie

$ 221.89 35,05% (12M)

P/E

169.26

2.87%

ROE

-91.88%

P/BV

-155.52

AZN - AstraZeneca

$ 96.34 49,81% (12M)

P/E

31.24

1.65%

ROE

20.45%

P/BV

6.39

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 834.16 43,58% (12 M)

P/L

25.09

0.38%

ROE

-697.75%

P/VP

-175.07

CAH - Cardinal Health

$ 213.56 73,39% (12 M)

P/L

30.01

1.01%

ROE

-58.40%

P/VP

-17.53

JNJ - Johnson & Johnson

$ 218.55 56,36% (12 M)

P/L

19.59

2.51%

ROE

31.69%

P/VP

6.21

MRK - Merck & Co.

$ 111.01 15,08% (12 M)

P/L

14.51

2.97%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.58 5,33% (12 M)

P/L

14.74

6.75%

ROE

10.56%

P/VP

1.56

ABBV - AbbVie

$ 221.89 35,05% (12 M)

P/L

169.26

2.87%

ROE

-91.88%

P/VP

-155.52

AZN - AstraZeneca

$ 96.34 49,81% (12 M)

P/L

31.24

1.65%

ROE

20.45%

P/VP

6.39

Frequently Asked Questions

What is the price of ADiTx Therapeutics (ADTX) today?

The price of ADiTx Therapeutics (ADTX) today is $ 0.73, with return of -99.98% compared to the last year. The price of ADiTx Therapeutics (ADTX) started the year trading around $ 0.83 and today it is at $ 0.73. Follow the real-time price chart, the historical price of ADiTx Therapeutics (ADTX) and international markets.

When does ADiTx Therapeutics (ADTX) pay dividends?

ADiTx Therapeutics (ADTX) did not distribute dividends in the last year.

Is ADiTx Therapeutics (ADTX) worth it?

Currently, ADiTx Therapeutics (ADTX) is priced at $ 0.73, with a P/E of -0.04%, representing a deviation of -30,424,184% from its historical average P/E. In the last year, the stock showed a variation of -99.98 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -99.98%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy ADiTx Therapeutics (ADTX) stock?

Investing in stocks of ADiTx Therapeutics (ADTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of ADiTx Therapeutics (ADTX) yield today?

The yield of ADiTx Therapeutics (ADTX) was -49.31% in the last month, -99.98% in the last year and -100.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of ADiTx Therapeutics (ADTX) today, the total investment would be $ 73.00, based on the current price of $ 0.73.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.01
In 5 years: $ 0.00
In 10 years: $ 73.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ADTX

ADiTx Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of ADTX

review the fundamentals of ADiTx Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY ADiTx Therapeutics

ADiTx Therapeutics Inc.

United States

9 years

2020

6

PROFIT X PRICE ADTX

Financial Results ADTX

ADTX cash flow

asset growth - ADTX

ADTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions